🏢 Company Profile
| Company Name | PET Pharm Biotech Co., Ltd. |
| English Name | PET Pharm Biotech Co., Ltd. |
| Ticker Symbol | 7762 |
| Paid-in Capital | NTD 580,913,340 |
| Date of Incorporation | October 3, 2011 |
| Chairman | John Yang |
| Spokesperson | Terry Lin (General Manager) |
| Deputy Spokesperson | Aaron Tsai (Chief Financial Officer) |
| Sponsoring Broker | Horizon Securities |
| Public Offering Date | July 17, 2024 |
| Emerging Stock Board Listing Date | July 25, 2024 |
| Company Address (Office) | 6F., No. 296, Jianguo 1st Rd., Xinzhuang Dist., New Taipei City, Taiwan |
| Company Address (Xinzhuang Plant) | No. 141, Hougang 1st Rd., Xinzhuang Dist., New Taipei City, Taiwan |
| Telephone | +886-2-2908-7790 |
| Fax | +886-2-2908-7750 |
| ir@petpharmbio.com | |
| Official Website | www.petpharmbio.com |
🧬 Core Business
- ▸Manufacturing and Sales of PIC/S GMP Sterile Preparations
- ▸Manufacturing and Sales of Molecular Imaging Drugs (Radiopharmaceuticals)
- ▸Research and Development of Novel Drugs
PET Pharm Biotech is one of the few manufacturers in Taiwan equipped with full supply capabilities for PET radiopharmaceuticals. Our product portfolio encompasses various nuclear medicine imaging agents, including Fluorodeoxyglucose (¹⁸F-FDG), serving major medical centers and teaching hospitals across Taiwan.
📋 Material Information Search
For complete disclosures, please visit the Market Observation Post System (MOPS) of the Financial Supervisory Commission (FSC). In case of any discrepancies, official announcements on MOPS shall prevail.
https://mops.twse.com.tw/mops/#/web/home
https://mops.twse.com.tw/mops/#/web/home
📈 Monthly Revenue Announcements
Monthly revenue reports are published on the Market Observation Post System (MOPS). Please enter our stock symbol 7762 to view detailed monthly revenue statements.
https://mops.twse.com.tw/mops/#/web/home
https://mops.twse.com.tw/mops/#/web/home